[Precision oncology and molecular tumor boards]

Area of Science:

• Oncology
• Genetics
• Personalized Medicine

Background:

• Precision oncology is a personalized medicine approach using tumor biology for tailored treatments.
• Current practice views cancers as genetic diseases driven by oncogene and tumor suppressor mutations.
• Molecular drugs target these genetic alterations, while next-generation sequencing identifies them.

Purpose of the Study:

• To advance precision oncology to a new standard of care.
• To improve the applicability of personalized molecular therapies.
• To ensure thorough scientific evaluation of precision oncology programs.

Main Methods:

• Utilizing next-generation sequencing for comprehensive analysis of tumor genetic aberrations.
• Developing and annotating rational molecular therapies with supporting evidence.
• Establishing molecular tumor boards for treatment recommendations.

Main Results:

• Molecular information enables matching appropriate treatments across different cancer types.
• Molecular tumor boards provide evidence-based therapeutic strategies.
• The field is advancing through the integration of genetic insights and targeted therapies.

Conclusions:

• Precision oncology offers tailored treatments based on individual tumor genetics.
• Further research and clinical evaluation are crucial for widespread adoption.
• Improved applicability and scientific validation are key to advancing precision oncology.